Clinical Trial: A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus

U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07321678) titled 'A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus' on Jan. 05.

Brief Summary: This randomized, double-blind, placebo-controlled Phase II study is designed to evaluate the efficacy, safety, and tolerability of ASC30 oral tablets formulation in participants with Type 2 Diabetes Mellitus

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: T2DM (Type 2 Diabetes Mellitus)

Intervention: DRUG: ASC30 tablets

ASC30 tablets administered orally once daily

DRUG: Placebo

Placebo administered orally once daily

Recruitment Status: RECRUITING

Sponsor: A...